Bain Capital Public Equity Management, LLC - Q2 2017 holdings

$1.66 Billion is the total value of Bain Capital Public Equity Management, LLC's 55 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .

 Value Shares↓ Weighting
JWN ExitNORDSTROM INCcall$0-7,500
-100.0%
0.00%
MRK ExitMERCK & CO INCput$0-12,300
-100.0%
-0.13%
GLOB ExitGLOBANT S A$0-134,900
-100.0%
-0.35%
TFX ExitTELEFLEX INC$0-25,800
-100.0%
-0.35%
MDT ExitMEDTRONIC PLC$0-62,800
-100.0%
-0.36%
SBAC ExitSBA COMMUNICATIONS CORP NEWcl a$0-43,491
-100.0%
-0.37%
IBKC ExitIBERIABANK CORP$0-74,190
-100.0%
-0.42%
XRX ExitXEROX CORP$0-892,700
-100.0%
-0.46%
EVHC ExitENVISION HEALTHCARE CORP$0-111,887
-100.0%
-0.49%
BMY ExitBRISTOL MYERS SQUIBB COput$0-12,000
-100.0%
-0.49%
SCG ExitSCANA CORP NEW$0-107,005
-100.0%
-0.50%
NKE ExitNIKE INCcl b$0-146,900
-100.0%
-0.58%
AZN ExitASTRAZENECA PLCsponsored adr$0-40,000
-100.0%
-0.63%
ARRS ExitARRIS INTL INC$0-348,000
-100.0%
-0.65%
MRK ExitMERCK & CO INC$0-149,400
-100.0%
-0.67%
ONCE ExitSPARK THERAPEUTICS INC$0-228,517
-100.0%
-0.86%
MGP ExitMGM GROWTH PPTYS LLC$0-451,387
-100.0%
-0.86%
VIAV ExitVIAVI SOLUTIONS INC$0-1,210,000
-100.0%
-0.92%
DOV ExitDOVER CORP$0-184,555
-100.0%
-1.05%
GPN ExitGLOBAL PMTS INC$0-224,922
-100.0%
-1.28%
MRK ExitMERCK & CO INCcall$0-41,000
-100.0%
-1.34%
RTN ExitRAYTHEON CO$0-130,750
-100.0%
-1.41%
HUM ExitHUMANA INC$0-99,753
-100.0%
-1.46%
LSXMK ExitLIBERTY MEDIA CORP DELAWARE$0-815,067
-100.0%
-2.24%
VOYA ExitVOYA FINL INC$0-893,863
-100.0%
-2.40%
CMCSA ExitCOMCAST CORP NEWcl a$0-1,150,336
-100.0%
-3.06%
LLL ExitL3 TECHNOLOGIES INC$0-285,008
-100.0%
-3.34%
PK ExitPARK HOTELS RESORTS INC$0-2,599,117
-100.0%
-4.72%
GD ExitGENERAL DYNAMICS CORP$0-450,496
-100.0%
-5.97%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Brookside Capital Investors, L.P. #1
  • Brookside Capital Partners Fund, L.P. #2
  • Brookside Capital Investors II, L.P. #3
  • Brookside Capital Trading Fund, L.P. #4
  • Brookside Capital Investors III, L.P. #5
  • Brookside Capital Partners Fund III, L.P. #6
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CITRIX SYS INC18Q3 20186.7%
QUINTILES TRANSNATIO HLDGS I18Q3 20173.5%
AFFIMED N V16Q1 20191.0%
BALL CORP13Q1 20197.2%
RADIUS HEALTH INC13Q2 20178.4%
TRANSDIGM GROUP INC11Q2 201610.1%
ULTA SALON COSMETCS & FRAG I11Q4 20155.4%
VIASAT INC11Q2 20177.5%
AETNA INC NEW11Q2 20174.1%
GODADDY INC10Q1 20195.7%

View Bain Capital Public Equity Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Bain Capital Public Equity Management, LLC Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Affimed N.V.February 14, 20192,362,8133.8%
IMMUNE DESIGN CORP.February 14, 2019892,0611.8%
REVA Medical, Inc.February 14, 2019296,502,2207.2%
MULESOFT, INCFebruary 14, 20181,404,0251.9%
CONCERT PHARMACEUTICALS, INC.February 28, 20141,147,8336.7%
IDENIX PHARMACEUTICALS INCFebruary 12, 201413,115,8589.8%
NORTHSTAR REALTY FINANCE CORP.February 12, 20147,657,7812.6%
PORTOLA PHARMACEUTICALS INCFebruary 12, 2014400,0001.0%
Dicerna Pharmaceuticals IncFebruary 10, 20141,337,0008.0%
RingCentral IncFebruary 07, 2014471,0735.5%

View Bain Capital Public Equity Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
SC 13G/A2019-02-14
SC 13G/A2019-02-14

View Bain Capital Public Equity Management, LLC's complete filings history.

Compare quarters

Export Bain Capital Public Equity Management, LLC's holdings